Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury

Respiratory Research

Volumn 18, Issue 1, 2017, Pages

  Camprubí Rimblas, Marta ^a,b   Guillamat Prats, Raquel ^a,c   Lebouvier, Thomas ^d,e   Bringué, Josep ^c   Chimenti, Laura ^a   Iglesias, Manuela ^f   Obiols, Carme ^f   Tijero, Jessica ^a   Blanch, Lluís ^a,c,g   Artigas, Antonio ^a,b,c,g  

^a PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e Univ Rennes   (France)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g Critical Care Center   (Spain)

Author keywords

Acute Respiratory Distress Syndrome (ARDS); Alveolar cells; Alveolar macrophages; Anticoagulants; Fibroblasts; Inflammation

Indexed keywords

HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID; CYTOKINE;

ACUTE LUNG INJURY; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DISEASE MODEL; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LUNG ALVEOLUS CELL; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROBLAST; MIDDLE AGED; PROTEIN EXPRESSION; CELL CULTURE; DRUG EFFECTS; FEMALE; FIBROBLAST; IMMUNOLOGY; LUNG ALVEOLUS; MACROPHAGE; MALE; PATHOLOGY; TREATMENT OUTCOME;

ACUTE LUNG INJURY; AGED; CELLS, CULTURED; CYTOKINES; FEMALE; FIBROBLASTS; HEPARIN; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MIDDLE AGED; PULMONARY ALVEOLI; TREATMENT OUTCOME;

EID: 85019112002     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-017-0572-3     Document Type: Article

References (34)

1. Ware LB, Bastarache JA, Wang L. Coagulation and fibrinolysis in human acute lung injury--new therapeutic targets? Keio J Med. 2005;54:142-9.
2. Hofstra J-JH, Juffermans NP, Schultz MJ, Zweers MM. Pulmonary coagulopathy as a new target in lung injury--a review of available pre-clinical models. Curr Med Chem. 2008;15:588-95.
3. Choi G, Wolthuis EK, Bresser P, Levi M, van der Poll T, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology. 2006;105:689-95.
4. Finigan JH. The coagulation system and pulmonary endothelial function in acute lung injury. Microvasc Res. 2009;77:35-8.
5. dos Santos CC, Slutsky AS. Mechanotransduction, ventilator-induced lung injury and multiple organ dysfunction syndrome. Intensive Care Med. 2000;26:638-42.
6. Oeckler RA, Hubmayr RD. Ventilator-associated lung injury: a search for better therapeutic targets. Eur Respir J. 2007;30:1216-26.
7. Villar J, Blanco J, Añón JM, Santos-Bouza A, Blanch L, Ambrós A, et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37:1932-41.
8. Idell S. Anticoagulants for acute respiratory distress syndrome: can they work? Am J Respir Crit Care Med. 2001;164:517-20.
9. Tuinman PR, Dixon B, Levi M, Juffermans NP, Schultz MJ. Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations. Crit Care Lond Engl. 2012;16:R70.
10. Dixon B, Schultz MJ, Hofstra JJ, Campbell DJ, Santamaria JD. Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury. Crit Care Lond Engl. 2010;14:445.
11. Glas GJ, Serpa Neto A, Horn J, Cochran A, Dixon B, Elamin EM, et al. Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis. Ann Intensive Care. 2016;6:33.
12. Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, et al. Unfractioned heparin for treatment of sepsis: a randomized clinical trial (the HETRASE study). Crit Care Med. 2009;37:1185-96.
13. Glas GJ, Muller J, Binnekade JM, Cleffken B, Colpaert K, Dixon B, et al. HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial. Trials. 2014;15:91.
14. Miller AC, Elamin EM, Suffredini AF. Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review. Crit Care Med. 2014;42:413-9.
15. Elsharnouby NM, Eid HEA, Abou Elezz NF, Aboelatta YA. Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses. J Crit Care. 2014;29:182.e1-4.
16. Ledson M, Gallagher M, Hart CA, Walshaw M. Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients. Eur Respir J. 2001;17:36-8.
17. Bendstrup KE, Gram J, Jensen JI. Effect of inhaled heparin on lung function and coagulation in healthy volunteers. Eur Respir J. 2002;19:606-10.
18. Li X, Zheng Z, Li X, Ma X. Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-ΚB activation on endothelial cell. Cytokine. 2012;60:114-21.
19. Fuchs S, Hollins AJ, Laue M, Schaefer UF, Roemer K, Gumbleton M, et al. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell Tissue Res. 2003;311:31-45.
20. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol. 2004;30:500-9.
21. Johnell M, Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg. 2002;124:321-32.
22. Bouma M, Maessen J, Weerwind P, Dentener M, Fransen E, de Jong D, et al. Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study. Chest. 1997;111:577-83.
23. Ning F, Wang X, Shang L, Wang T, Lv C, Qi Z, et al. Low molecular weight heparin may prevent acute lung injury induced by sepsis in rats. Gene. 2015;557:88-91.
24. Puig F, Fuster G, Adda M, Blanch L, Farre R, Navajas D, et al. Barrier-protective effects of activated protein C in human alveolar epithelial cells. PLoS One. 2013;8:e56965.
25. Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, et al. Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med. 2008;36:2973-9.
26. Suter PM. Nebulised heparin: a new approach to the treatment of acute lung injury? Crit Care Lond Engl. 2008;12:170.
27. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765-77.
28. Haeffner-Cavaillon N, Cavaillon JM, Moreau M, Szabó L. Interleukin 1 secretion by human monocytes stimulated by the isolated polysaccharide region of the Bordetella pertussis endotoxin. Mol Immunol. 1984;21:389-95.
29. Raymondos K, Martin MU, Schmudlach T, Baus S, Weilbach C, Welte T, et al. Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma. Injury. 2012;43:189-95.
30. Aggarwal NR, King LS, D'Alessio FR. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol. 2014;306:L709-725.
31. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care Lond Engl. 2007;11:R49.
32. Mu E, Ding R, An X, Li X, Chen S, Ma X. Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and TGF-β/Smad signaling pathway. Thromb Res. 2012;129:479-85.
33. Feng Y, Yang Q, Xu J, Qian G, Liu Y. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. Exp Mol Pathol. 2008;85:214-22.
34. Puig F, Herrero R, Guillamat-Prats R, Gómez MN, Tijero J, Chimenti L, et al. A new experimental model of acid and endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2016. doi: 10.1152/ajplung.00390.2015.